Novartis’ Mayzent could preserve mobility in MS patients

12th September 2019 Uncategorised 0

The average time to when patients require a wheelchair could be extended from 12 years to 16.3 years.

More: Novartis’ Mayzent could preserve mobility in MS patients
Source: News